Skip to content
Home/Companies/MedTech/Sirigen

Sirigen

MedTech·UK·Exited 2012·Held 2yr
Entry
2010
Hold
2yr
Exit
2012

Who owns Sirigen?

Sirigen was owned by IQ Capital Partners through IQ Capital Fund I (2007 vintage) from 2010 to 2012, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-16

IQ Capital Partners
Investor
IQ Capital Partners
IQ Capital Fund I · 2007 · VC

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2012

More from IQ Capital Fund I

Other portfolio companies in the same fund.

Bloomsbury AI
Exited 2018
AI/MLUK· 2017
to
Speechmatics
Speechmatics
Active
AI/MLUK· 2017
Neul
Exited 2014
TelecomUK· 2011
to
Power Challenge
Exited 2012
GamingSweden· 2010
to
Rosslyn
Exited 2014
Data & AnalyticsUK· 2010
Grapeshot
Exited 2018
AdTechUK· 2009
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Sirigen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sirigen?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sirigen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue